Abstract: This study investigated the protective effect of the compatibility of hypaconitine (HA) and glycyrrhetinic acid (GA) on H9c2 cells under oxygen and glucose deprivation (OGD)-induced injury, and the possible mechanisms. We found that HA+GA significantly improved pathology and morphology of the nucleus and ultrastructure of H9c2 cells under OGD as determined by Hoechst 33342 staining and transmission electron microscopy (TEM) tests. It also reduced the releases of lactate dehydrogenase (LDH), creatine kinase-myocardial band isoenzyme (CK-MB), and aspartate transaminase (AST) from the cultured supernatant of H9c2 cells, which were tested by enzyme-linked immune sorbent assay (ELISA) kits. In addition, it lessened the apoptotic rate as determined by a fluorescein isothiocyanate-annexin V/propidium iodide (FITC-AV/PI) double staining assay. It was also found that HA+GA might regulate the protein expression associated with the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. Overall, the study demonstrated that HA+GA protected H9c2 cells against OGD-induced injury, and the signaling mechanism might be related to the PI3K/Akt signaling pathway.

次乌头碱配伍甘草次酸对缺氧缺糖损伤H9c2心肌细胞的保护作用及其分子机制

[1]Cai, Y., Gao, Y., Tan, G., et al., 2013. Myocardial lipidomics profiling delineate the toxicity of traditional Chinese medicine Aconiti Lateralis radix praeparata. J. Ethnopharmacol., 147(2):349-356.

[2]Chen, Z., Shen, X., Shen, F., et al., 2013. TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70. Mol. Cell. Biochem., 377(1-2):35-44.

[3]Fan, R., Li, N., Xu, H., et al., 2016. The mechanism of hydrothermal hydrolysis for glycyrrhizic acid into glycyrrhetinic acid and glycyrrhetinic acid 3-O-mono-β-D-glucuronide in subcritical water. Food Chem., 190:912-921.

[4]Freude, B., Masters, T.N., Robicsek, F., et al., 2000. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J. Mol. Cell. Cardiol., 32(2):197-208.

[5]Gao, F., Hu, X.Y., Xie, X.J., et al., 2010. Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the PI3K/Akt and ERK1/2 pathways. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 11(8):608-617.

[6]Gao, Q.T., Chen, X.H., Bi, K.S., 2004. Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang. Biol. Pharm. Bull., 27(2):226-228.

[7]He, W., Zhang, M.F., Ye, J., et al., 2010. Cordycepin induces apoptosis by enhancing JNK and p38 kinase activity and increasing the protein expression of Bcl-2 pro-apoptotic molecules. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 11(9):654-660.

[8]Hemmings, B.A., Restuccia, D.F., 2012. PI3K-PKB/Akt pathway. Cold Spring Harb. Perspect. Biol., 4(9):a011189.

[9]Lai, C.C., Tang, C.Y., Chiang, S.C., et al., 2015. Ischemic preconditioning activates prosurvival kinases and reduces myocardial apoptosis. J. Chin. Med. Assoc., 78(8):460-468.

[10]Lee, Y., Gustafsson, A.B., 2009. Role of apoptosis in cardiovascular disease. Apoptosis, 14(4):536-548.

[11]Liu, Q.Y., Zhang, Y.Y., Wan, H.T., et al., 2013. Detoxicated effect of compatibility of hypaconitine and liquiritin, glycyrrhetinic acid. China J. Tradit. Chin. Med. Pharm., 28(9):2601-2604.

[12]Liu, T., Zhu, W., Yang, X., et al., 2009. Detection of apoptosis based on the interaction between annexin V and phosphatidylserine. Anal. Chem., 81(6):2410-2413.

[13]Marambio, P., Toro, B., Sanhueza, C., et al., 2010. Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim. Biophys. Acta, 1802(6):509-518.

[14]Menezes, A.R., Lavie, C.J., Milani, R.V., et al., 2011. Psychological risk factors and cardiovascular disease: is it all in your head? Postgrad. Med., 123(5):165-176.

[15]Munk, P.S., Larsen, A.I., 2009. Inflammation and C-reactive protein in cardiovascular disease. Tidsskr. Nor. Laegeforen., 129(12):1221-1224 (in Norwegian).

[16]Nabel, E.G., Braunwald, E., 2012. A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med., 366(1):54-63.

[17]Oudit, G.Y., Penninger, J.M., 2009. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc. Res., 82(2):250-260.

[18]Qiao, S., Mao, X., Wang, Y., et al., 2016. Remifentanil preconditioning reduces postischemic myocardial infarction and improves left ventricular performance via activation of the Janus activated kinase-2/signal transducers and activators of transcription-3 signal pathway and subsequent inhibition of glycogen synthase kinase-3β in rats. Crit. Care Med., 44(3):e131-e145.

[19]Quan, W., Wu, B., Bai, Y., et al., 2014. Magnesium lithospermate B improves myocardial function and prevents simulated ischemia/reperfusion injury-induced H9c2 cardiomyocytes apoptosis through Akt-dependent pathway. J. Ethnopharmacol., 151(1):714-721.

[20]Rizvi, M., Jawad, N., Li, Y., et al., 2010. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp. Biol. Med. (Maywood), 235(7):886-891.

[21]Shang, M., Zhang, Q., Zhang, M.X., et al., 2013. Effects of endothelial microvesicles induced by A23187 on H9c2 cardiomyocytes. Chin. J. Appl. Physiol., 29(6):559-564.

[22]Shi, R., Liu, L., Huo, Y., et al., 2007. Study on protective effects of Panax notoginseng saponins on doxorubicin-induced myocardial damage. China J. Chin. Mat. Med., 32(24):2632-2635 (in Chinese).

[23]Sun, X., Chen, R.C., Yang, Z.H., et al., 2014. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis. Food Chem. Toxicol., 63:221-232.

[24]Thompson, C.B., 1995. Apoptosis in the pathogenesis and treatment of disease. Science, 267(5203):1456-1462.

[25]Tong, H., Chen, W., Steenbergen, C., et al., 2000. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ. Res., 87(4):309-315.

[26]van der Hoeven, B.L., Schalij, M.J., Delgado, V., 2012. Multimodality imaging in interventional cardiology. Nat. Rev. Cardiol., 9(6):333-346.

[27]Vermes, I., Haanen, C., Steffens-Nakken, H., et al., 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184(1):39-51.

[28]Wakayama, K., Fukai, M., Yamashita, K., et al., 2012. Successful transplantation of rat hearts subjected to extended cold preservation with a novel preservation solution. Transpl. Int., 25(6):696-706.

[29]Wang, J., Ji, S.Y., Liu, S.Z., et al., 2015. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury. Pharmazie, 70(9):593-597.

[30]Wang, J.X., Zhang, X.J., Li, Q., et al., 2015. MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ. Res., 117(4):352-363.

[31]Wu, H.J., Yang, J.Y., Jin, M., et al., 2015. Glycyrrhetinic acid protects the heart from ischemia/reperfusion injury by attenuating the susceptibility and incidence of fatal ventricular arrhythmia during the reperfusion period in the rat hearts. Cell. Physiol. Biochem., 36(2):741-752.

[32]Xie, S., Jia, Y., Liu, A., et al., 2015. Hypaconitine-induced QT prolongation mediated through inhibition of KCNH2 (hERG) potassium channels in conscious dogs. J. Ethnopharmacol., 166:375-379.

[33]Yang, Y., Yin, X.J., Guo, H.M., et al., 2014. Identification and comparative analysis of the major chemical constituents in the extracts of single Fuzi herb and Fuzi-Gancao herb-pair by UFLC-IT-TOF/MS. Chin. J. Nat. Med., 12(7):542-553.

[34]Yu, B., Cao, Y., Xiong, Y.K., 2015. Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry. J. Ethnopharmacol., 165:173-179.

[35]Yu, H.T., Zhen, J., Pang, B., et al., 2015. Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 16(5):344-354.

[36]Yu, L.N., Yu, J., Zhang, F.J., et al., 2010. Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of Bcl-2 family proteins. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 11(9):661-672.

[37]Yucel, A.F., Kanter, M., Pergel, A., et al., 2011. The role of curcumin on intestinal oxidative stress, cell proliferation and apoptosis after ischemia/reperfusion injury in rats. J. Mol. Histol., 42(6):579-587.

[38]Yue, H., Pi, Z.F., Li, H.L., et al., 2008. Studies on the stability of diester-diterpenoid alkaloids from the genus Aconitum L. by high performance liquid chromatography combined with electrospray ionisation tandem mass spectrometry (HPLC/ESI/MSⁿ). Phytochem. Anal., 19(2):141-147.

[39]Zhang, J.M., Liao, W., He, Y.X., et al., 2013. Study on intestinal absorption and pharmacokinetic characterization of diester diterpenoid alkaloids in precipitation derived from Fuzi-Gancao herb-pair decoction for its potential interaction mechanism investigation. J. Ethnopharmacol., 147(1):128-135.

[40]Zhang, W., Zhang, H., Sun, S., et al., 2015. Comparative pharmacokinetics of hypaconitine after oral administration of pure hypaconitine, Aconitum carmichaelii extract and Sini Decoction to rats. Molecules, 20(1):1560-1570.

[41]Zhao, D., Wang, J., Cui, Y., et al., 2012. Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular system. J. Tradit. Chin. Med., 32(3):308-313.

[42]Zheng, K., Sheng, Z., Li, Y., et al., 2014. Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating of Akt-Nrf2 signaling. Biochem. Biophys. Res. Commun., 451(1):79-85.

[43]Zhou, G., Tang, L., Zhou, X., et al., 2015. A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux. J. Ethnopharmacol., 160:173-193.